Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Ciclosporin Pro versus Sandimmun Optoral under fasting and fed conditions in stable renal transplant patients
2009-011354-18Phase 4Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Dec 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in kidney allograft rejection (2 arms), sponsored by Universitätsmedizin Essen. Primary endpoint: Reduction of bioavailability due to high-fat food. Started Dec 2009; status: completed.
02
Drugs
cyclosporine
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2009-011354-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011354-18.